Immix Biopharma (IMMX) Net Equity Issued and Repurchased (2022 - 2026)
Immix Biopharma (IMMX) recorded Net Equity Issued and Repurchased of $140.69 million in Q2 2026.
Powered by 
Analysis
Immix Biopharma (IMMX) Net Equity Issued and Repurchased (2022 - 2026) Analysis & Trends
On a TTM basis, Immix Biopharma's Net Equity Issued and Repurchased came in at $248.11 million as of Jun 30, 2026; for FY2025, it came in at $107.39 million, up 573.5% from FY2024.
- Annual Net Equity Issued and Repurchased has increased for three straight years, with a four-year compound annual growth rate of 54.9% (FY2021 to FY2025).
- Across earlier years, Net Equity Issued and Repurchased came in at $15.95 million in FY2024 (+2.7%), $15.52 million in FY2023 (+432.7%), $2.91 million in FY2022 (-84.4%) and $18.65 million in FY2021.
- The Q2 2026 figure is the highest quarterly Net Equity Issued and Repurchased in data going back to Q1 2022.
- Per Business Quant, the preceding three quarters came in at $33,532 (Q1 2026), $95.51 million (Q4 2025) and $11.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Immix Biopharma | 743.97 Mn | 743.97 Mn | - | 140.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 140.69 Mn |
| Mar 31, 2026 | 33,532.00 |
| Dec 31, 2025 | 95.51 Mn |
| Sep 30, 2025 | 11.87 Mn |
| Mar 31, 2024 | 15.95 Mn |
| Dec 31, 2023 | 584,073.00 |
| Sep 30, 2023 | 10.13 Mn |
| Jun 30, 2023 | 4.64 Mn |
| Mar 31, 2023 | 175,000.00 |
| Mar 31, 2022 | 2.91 Mn |
API Access
Immix Biopharma Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();